Aurinia Pharmaceuticals Inc. (AUPH) Shareholders’ equity 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) shareholders’ equity at each fiscal year-end, per SEC filings.
$581.3MFY2025 · since FY2018: $135.7M → $581.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $581.3M | +54.0% |
| FY2024 | $377.5M | -0.1% |
| FY2023 | $378.0M | -6.8% |
| FY2022 | $405.4M | -15.4% |
| FY2021 | $479.1M | +17.5% |
| FY2020 | $407.8M | +36.6% |
| FY2019 | $298.6M | +120.0% |
| FY2018 | $135.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice